Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors

NCT02268435 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Dovitinib Production stopped

Conditions

Interventions

Sponsor

Asan Medical Center